Back to Search
MARTIN WIESENFELD, M.D., F.A.C.P.
M.D., F.A.C.P.
Medical Oncology Physician
NPI: 1740265404Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
20679(IA)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
20679(IA)
Research & Publications (14)
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
PMID 19066728·J Neurooncol·2009
3-trial
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.
PMID 19047293·J Clin Oncol·2009
3-trial
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
PMID 17613756·Leuk Lymphoma·2007
3-trial
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.
PMID 17187355·Int J Cancer·2007
8-other
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.
PMID 16085692·Ann Oncol·2005
3-trial
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
PMID 15117979·J Clin Oncol·2004
4-observational
Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study.
PMID 14528068·Am J Clin Oncol·2003
3-trial
Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
PMID 12796591·Am J Clin Oncol·2003
3-trial
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.
PMID 12745490·Nicotine Tob Res·2003
3-trial
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.
PMID 12649105·Ann Oncol·2003
3-trial
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.
PMID 12056705·Ann Oncol·2002
3-trial
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.
PMID 11801752·Am J Clin Oncol·2001
3-trial
A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index.
PMID 11481361·J Clin Oncol·2001
4-observational
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
PMID 10690544·Clin Cancer Res·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 701 10TH ST SE, HPCC 3RD FLOOR
CEDAR RAPIDS, IA 52403 - Phone
- (319) 363-8303
Quick Facts
- NPI
- 1740265404
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile